MONDINI, LUCREZIA
 Distribuzione geografica
Continente #
NA - Nord America 1.301
AS - Asia 1.236
EU - Europa 734
SA - Sud America 126
Continente sconosciuto - Info sul continente non disponibili 68
AF - Africa 34
OC - Oceania 1
Totale 3.500
Nazione #
US - Stati Uniti d'America 1.237
SG - Singapore 423
IT - Italia 278
CN - Cina 246
VN - Vietnam 167
BR - Brasile 105
HK - Hong Kong 101
BD - Bangladesh 85
DE - Germania 80
KR - Corea 71
GB - Regno Unito 68
FI - Finlandia 59
FR - Francia 55
NL - Olanda 51
CA - Canada 36
PL - Polonia 28
TR - Turchia 26
IN - India 25
RU - Federazione Russa 22
IE - Irlanda 16
JP - Giappone 16
SE - Svezia 16
MX - Messico 13
ID - Indonesia 12
IQ - Iraq 12
AT - Austria 10
ES - Italia 10
MA - Marocco 10
CH - Svizzera 9
AR - Argentina 8
PK - Pakistan 7
SA - Arabia Saudita 6
UA - Ucraina 6
UZ - Uzbekistan 6
EG - Egitto 5
IL - Israele 5
PH - Filippine 5
ZA - Sudafrica 5
BE - Belgio 4
BY - Bielorussia 4
HN - Honduras 4
CO - Colombia 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
IR - Iran 3
PY - Paraguay 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AO - Angola 2
AZ - Azerbaigian 2
DZ - Algeria 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
TN - Tunisia 2
TW - Taiwan 2
VE - Venezuela 2
AM - Armenia 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
BZ - Belize 1
CG - Congo 1
CL - Cile 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KE - Kenya 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MG - Madagascar 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
Totale 3.432
Città #
Singapore 223
Ashburn 185
San Jose 180
Council Bluffs 113
Hefei 97
Hong Kong 96
Seoul 70
Ho Chi Minh City 64
Los Angeles 53
Beijing 41
Hanoi 37
Trieste 37
New York 33
London 32
Columbus 29
Santa Clara 29
Chicago 27
Munich 27
Frankfurt am Main 26
Helsinki 22
Lauterbourg 22
Lappeenranta 21
Boardman 20
Dallas 20
Phoenix 20
Milan 19
The Dalles 17
Turku 16
Zgierz 16
Dublin 15
Tokyo 15
São Paulo 14
Adana 13
Toronto 13
Buffalo 12
Montreal 12
Manchester 11
Casablanca 10
Moscow 10
Orem 10
Rome 9
Atlanta 8
Haiphong 8
Houston 8
Mumbai 8
Pordenone 8
Tampa 8
Warsaw 8
Brooklyn 7
Chandler 7
Chennai 7
Denver 7
Düsseldorf 7
Naples 7
Nuremberg 7
Baghdad 6
Brescia 6
Da Nang 6
Florence 6
Pietrasanta 6
Tashkent 6
Treviso 6
Udine 6
Vienna 6
Amsterdam 5
Ankara 5
Azzano Decimo 5
Barnet 5
Bologna 5
Dhaka 5
Falkenstein 5
Jacksonville 5
Mexico City 5
Modena 5
Newark 5
Poplar 5
Rio de Janeiro 5
Salt Lake City 5
Zurich 5
Bern 4
Brasília 4
Erie 4
Hải Dương 4
Istanbul 4
La Mirada 4
Miami 4
North Bergen 4
Oklahoma City 4
Palermo 4
Perham 4
Redondo Beach 4
Reno 4
Seattle 4
Shanghai 4
Shenzhen 4
Stockholm 4
Turin 4
Venice 4
Vista 4
Anzio 3
Totale 2.053
Nome #
Comorbidities’ Effect on IPF: Pathogenesis and Management 231
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows 224
Assessment of Treatment Effects of Aminaphtone by Capillaroscopy in a Patient with Raynaud’s Phenomenon 202
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study 183
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? 181
Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go? 171
The Impact of Comorbidities on the Discontinuation of Antifibrotic Therapy in Patients with Idiopathic Pulmonary Fibrosis 169
Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease 156
Host-Based Treatments for Severe COVID-19 146
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints 144
Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature—Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment 143
Nailfold Capillaroscopy Analysis Can Add a New Perspective to Biomarker Research in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 140
Nailfold Video-Capillaroscopy in Sarcoidosis: New Perspectives and Challenges 140
A novel technique for conducting flexible bronchoscopy cryobiopsy under conscious sedation: An observational study 140
Autoantibodies in sarcoidosis: innocent bystander or promising biomarker for organ involvement? 135
Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant 135
Biomarkers in Systemic Sclerosis: An Overview 131
Analyzing Sarcoidosis via Nailfold Capillaroscopy: Microvascular Insights 125
Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation 118
Exploring sarcoidosis via nailfold capillaroscopy: A window into the disease’s microvascular landscape 113
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy 113
Evaluation of Nailfold Capillaroscopy as a Novel Tool in the Assessment of Eosinophilic Granulomatosis with Polyangiitis. 100
Cardiac sarcoidosis recurrence post-heart transplant: A critical literature and case report 93
First evaluation of microvascular damage through nailfold capillaroscopy of an uncommon case of Raynaud's phenomenon in multiple sclerosis: Case report and literature review 67
Totale 3.500
Categoria #
all - tutte 11.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 0 0 0 0 0 0 4
2022/202334 3 3 2 2 2 5 0 3 5 0 4 5
2023/2024152 6 7 6 15 13 10 32 31 6 3 19 4
2024/2025664 30 23 41 62 49 47 20 31 72 105 78 106
2025/20262.210 196 132 158 250 168 178 307 73 215 234 186 113
2026/2027436 143 180 113 0 0 0 0 0 0 0 0 0
Totale 3.500